home
portfolio
team
careers
contact
investor portal
home
portfolio
team
careers
contact
investor portal
Nextech Invest
Silverback Therapeutics Announces Pricing of Initial Public Offering
Silverback Therapeutics Announces Pricing of Initial Public Offering
Post navigation
Previous Post
Previous
Kronos Bio Announces FDA Clearance of Investigational New Drug (IND) Application for KB-0742, an Oral CDK9 Inhibitor Targeting MYC-amplified Cancers
Next Post
Next
Kinnate Biopharma Announces Pricing of Initial Public Offering